DDR2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1
Open Access
- 11 September 2015
- journal article
- research article
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 34 (1) , 1-13
Abstract
Several studies have found that DDR2 is up-regulated in many tumor types and facilitates tumor progression. However, the role of DDR2 in hepatocellular carcinoma (HCC) progression and its downstream signaling pathways remain unclear. DDR2 expression was assessed in several cell lines and 112 pairs of HCC and matched adjacent noncancerous liver tissues. Clinical significance of DDR2 in HCC was analyzed. Phosphorylated DDR2 (p-DDR2) expression was detected by immunoblotting to evaluate its correlation with DDR2. The effect of DDR2 on HCC cell migration and invasion were examined. Cycloheximide chase experiments were performed to detect the half-life of SNAIL1. Moreover, DDR2 expression was detected by immunohistochemistry to evaluate its correlation with SNAIL1. The regulatory effect of DDR2 on ERK signaling, SNAIL1, EMT, MT1-MMP and MMP2 was confirmed by immunoblotting. The effect of type I collagen on DDR2/ERK2/SNAIL1 signaling was assessed. DDR2 was more highly expressed in HCC than in non-HCC tissues. DDR2 overexpression was correlated with clinicopathological features of poor prognosis. Clinical analysis revealed that DDR2 is an independent prognostic marker for predicting overall survival and disease free survival of HCC patients. Overexpression of DDR2 is associated with p-DDR2 amplification. In vitro studies showed that DDR2 facilitates HCC cell invasion, migration and EMT via activating ERK2 and stabilizing SNAIL1. DDR2 can up-regulate MT1-MMP and MMP2 expression through ERK2/SNAIL1 signaling in HCC. Additionally, collagen I can induce DDR2/ERK2/SNAIL1 signaling activation in HCC cells. Our findings suggest that DDR2 plays an important role in promoting HCC cell invasion and migration, and may serve as a novel therapeutic target in HCC.Keywords
Funding Information
- National Natural Science Foundation of China (30600156)
- Natural Science Foundation of Guangdong Province (2014A030313090)
- Natural Science Foundation of Guangdong Province (2014A030313190)
- Science and Technology Projects Foundation of Jiangxi Province (20151BBG70085)
- Science and Technology Projects Foundation of Guangzhou City (1515000250)
This publication has 35 references indexed in Scilit:
- The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasisNature Cell Biology, 2013
- Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinomaBMC Cancer, 2013
- High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinomaJournal of Experimental & Clinical Cancer Research, 2013
- Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticityBreast Cancer Research, 2011
- The role of signaling pathways in the development and treatment of hepatocellular carcinomaOncogene, 2010
- Epithelial–Mesenchymal Transition in Hepatocellular CarcinomaFuture Oncology, 2009
- Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005Journal of Clinical Oncology, 2009
- Trends in mortality from hepatocellular carcinoma in Europe, 1980‐2004†Hepatology, 2008
- Upregulation of discoidin domain receptor 2 in nasopharyngeal carcinomaHead & Neck, 2007
- Activation of the Discoidin Domain Receptor 2 Induces Expression of Matrix Metalloproteinase 13 Associated with Osteoarthritis in Mice*♦Journal of Biological Chemistry, 2005